These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8225235)
1. Bile acids for babies? Diagnosis and treatment of a new category of metabolic liver disease. Suchy FJ Hepatology; 1993 Nov; 18(5):1274-7. PubMed ID: 8225235 [No Abstract] [Full Text] [Related]
2. [Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders]. Kondo KH; Maeda Y; Setoguchi T Ryoikibetsu Shokogun Shirizu; 1995; (8):362-6. PubMed ID: 8581653 [No Abstract] [Full Text] [Related]
3. An infant with 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase deficiency presenting with typical neonatal hepatitis syndrome: the first Japanese case. Terazawa S; Kimura A; Inoue T; Murai T; Kurosawa T; Takao A Acta Paediatr Jpn; 1998 Dec; 40(6):638-40. PubMed ID: 9893307 [No Abstract] [Full Text] [Related]
4. Inborn errors of metabolism with consequences for bile acid biosynthesis. A minireview. Björkhem I Scand J Gastroenterol Suppl; 1994; 204():68-72. PubMed ID: 7824882 [TBL] [Abstract][Full Text] [Related]
5. The identification of unusual bile acid metabolites by tandem mass spectrometry: use of low-energy collision-induced dissociation to produce informative spectra. Lemonde HA; Johnson AW; Clayton PT Rapid Commun Mass Spectrom; 1999; 13(12):1159-64. PubMed ID: 10390861 [TBL] [Abstract][Full Text] [Related]
6. A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency. Jacquemin E; Setchell KD; O'Connell NC; Estrada A; Maggiore G; Schmitz J; Hadchouel M; Bernard O J Pediatr; 1994 Sep; 125(3):379-84. PubMed ID: 7915305 [TBL] [Abstract][Full Text] [Related]
7. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Setchell KD; Heubi JE; Bove KE; O'Connell NC; Brewsaugh T; Steinberg SJ; Moser A; Squires RH Gastroenterology; 2003 Jan; 124(1):217-32. PubMed ID: 12512044 [TBL] [Abstract][Full Text] [Related]
8. Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. Gonzales E; Gerhardt MF; Fabre M; Setchell KD; Davit-Spraul A; Vincent I; Heubi JE; Bernard O; Jacquemin E Gastroenterology; 2009 Oct; 137(4):1310-1320.e1-3. PubMed ID: 19622360 [TBL] [Abstract][Full Text] [Related]
9. Screening techniques for the detection of inborn errors of bile acid metabolism by direct injection and micro-high performance liquid chromatography-continuous flow/fast atom bombardment mass spectrometry. Evans JE; Ghosh A; Evans BA; Natowicz MR Biol Mass Spectrom; 1993 Jun; 22(6):331-7. PubMed ID: 8329462 [TBL] [Abstract][Full Text] [Related]
10. Bile acid synthetic defects and liver disease: a comprehensive review. Bove KE; Heubi JE; Balistreri WF; Setchell KD Pediatr Dev Pathol; 2004; 7(4):315-34. PubMed ID: 15383928 [TBL] [Abstract][Full Text] [Related]
16. Urinary bile acid profile in children with inborn errors of bile acid metabolism and chronic cholestasis; screening technique using electrospray tandem mass-spectrometry (ES/MS/MS). Yousef IM; Perwaiz S; Lamireau T; Tuchweber B Med Sci Monit; 2003 Mar; 9(3):MT21-31. PubMed ID: 12640349 [TBL] [Abstract][Full Text] [Related]
17. Urinary bile acids and peroxisomal bifunctional enzyme deficiency. Natowicz MR; Evans JE; Kelley RI; Moser AB; Watkins PA; Moser HW Am J Med Genet; 1996 May; 63(2):356-62. PubMed ID: 8725785 [TBL] [Abstract][Full Text] [Related]
18. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Lindblad A; Glaumann H; Strandvik B Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933 [TBL] [Abstract][Full Text] [Related]
19. Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency). Daugherty CC; Setchell KD; Heubi JE; Balistreri WF Hepatology; 1993 Nov; 18(5):1096-101. PubMed ID: 8225213 [TBL] [Abstract][Full Text] [Related]
20. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency. Ueki I; Kimura A; Chen HL; Yorifuji T; Mori J; Itoh S; Maruyama K; Ishige T; Takei H; Nittono H; Kurosawa T; Kage M; Matsuishi T J Gastroenterol Hepatol; 2009 May; 24(5):776-85. PubMed ID: 19175828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]